Technological advancements in neuroscience on continuous basis is the factor basically augmenting the neurosurgery market. Neurological conditions including dementia, traumatic brain injuries, multiple sclerosis, neurological disorders associated with stroke, malnutrition, epilepsy, and Parkinson’s disease may prove to be fatal if not attended on time.
Some of them can be brought under control through neurosurgery, whereas some like Parkinson’s and dementia could be controlled through holistic therapeutics. Rise in the number of patients opting for personalized medicines is another factor driving the neurosurgery industry.
The companies operating in the neurosurgery market are working toward installation of neurosurgery electrosurgical units. They are also exploring the incorporation of AI in neurosurgery, which is being looked upon as a novel era regarding precision medicine.
These upgradations are bound to open new avenues for collaborations between research centers and the key players in the near future.
Neurosurgery is the medical specialty pertaining to diagnosis and treatment of the patients suffering from injury/disorders/disease of the spinal cord, brain, and spinal column, and also the peripheral nerves within the body. Neurosurgical care covers pediatric as well as adult patients. The nature of disease or injury decides whether the patient should receive non-surgical or surgical care.
Growing prevalence of neurological conditions such as intracerebral hemorrhage (ICH), transnasal hemorrhage, chronic pain, traumatic brain injury, Parkinson’s, and depression is driving the market for neurosurgery.
However, high costs of products such as neurovascular coiling devices, neurovascular embolization devices, and neuroendoscopes may restrain the neurosurgery market, especially in the low-income economies.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Modern neurosurgery involves high-level understanding of the cerebral form and function for more effectively treating complex pathologies that affect patients. In other words, technological advancements have brought in a transition toward energy-efficient equipment from traditional equipment on the basis of new-fangled technology.
Along the above-mentioned lines, in April 2022, Abbott Laboratories announced that it had introduced an upgraded version of its NeuroSphere myPath digital health app with improved functionality that would be aiding doctors in tracking their patients more closely.
This upgradation is a part of the company’s commitment to connected care and intends putting people in control of health and enable a higher level of communication with doctors.
In April 2022, Boston Scientific Corporation announced that it had received approval from the U.S. FDA for its Vercise Neural Navigator, an image-guiding software, along with STIMVIEW XT. It has been developed in collaboration with Brainlab AG.
In October 2020, Accuracy Inc. announced that it had inked a collaboration agreement with the same Brainlab AG for expanding Accuracy CyberKnife treatment platform to help in neurosurgeries.
Technological upgradations through continual collaborations and inventions are thus contributing toward neurosurgery market growth.
Personalized medicine, which means matching medical treatments to the needs and genetic composition of an individual, is one of the emerging paradigms in neurosurgery. Moreover, obtaining consent of the patient for genetic testing needs to be addressed.
The healthcare personnel can thus unleash fundamental causes of brain tumors and neurological diseases BY evaluation of genetic material of a patient, thereby allowing formulation of the individualized treatment strategies.
Personalized medicine provides a customized risk-benefit analysis for making well-informed decisions regarding course of action. The technique thus helps patients in looking through the probable advantages and restraints.
Personalized medicine is bound to revolutionize the neurological practice, thereby raising the level of diagnosis and treatment of brain tumors and neurological disorders, thereby resulting in enhanced patient outcomes and provision of more efficient healthcare services. The factors mentioned above are thus expanding the neurosurgery market size.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest neurosurgery market insights, North America led the neurosurgery landscape in 2023 and the status quo is expected to remain unchanged during the forecast period. This is attributed to the key players focusing on upgradation of the existing devices to better serve the patients.
For instance, in July 2023, Anucia Medical launched a send-generation device for treating hydrocephalus at various topnotch neurosurgery hospitals in the U.S.
Europe’s significant neurosurgery market growth is ascribed to Germany leading in development of various innovative methods in order to improve neuromodulation and neurostimulation technology.
The key participants in the neurosurgery market are opting for new product launch to make a mark in the neurosurgery landscape.
For instance, in March 2022, Medtronic announced launching of their first patient implants in TITAN 2 pivotal study, which was aimed at evaluating efficacy and safety of its investigational implantable tibial neuromodulation (TNM) device with people battling overactive bladder (OAB).
Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Elekta, Aleva Neurotherapeutics, Machida Endoscope Co., Ltd., Brainlab, adeor Medical AG, LivaNova, plc, B. Braun, Optofine Instruments Pvt. Ltd., Wallaby Medical, LLC, Terumo Medical Corporation, Integra LifeSciences, and Stryker Tech are some of the key players spanning the neurosurgery market report scope.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 4.2 Bn |
| Market Forecast (Value) in 2034 | US$ 6.8 Bn |
| Growth Rate (CAGR) | 4.5% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 4.2 Bn in 2023
It is projected to grow at a CAGR of 4.5% from 2024 to 2034
Technological advancements in neuroscience and rise in inclination toward personalized medicine
Hospitals and specialty clinics segment accounted for the largest share in 2023
North America was the dominant region in 2023
Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Elekta, Aleva Neurotherapeutics, Machida Endoscope Co., Ltd., Brainlab, adeor Medical AG, LivaNova, plc, B. Braun, Optofine Instruments Pvt. Ltd., Wallaby Medical, LLC, Terumo Medical Corporation, Integra LifeSciences, and Stryker Tech
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Neurosurgery Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Neurosurgery Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Neurosurgery Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2020-2034
6.3.1. Neuro Interventional Devices
6.3.2. Neuroendoscopes
6.3.3. Neurosurgical Drills
6.3.4. Radiosurgery Systems
6.3.5. Dura Substitutes
6.3.6. Neurosurgical Ablation Devices
6.3.7. Neurosurgery Instruments
6.4. Market Attractiveness Analysis, by Product Type
7. Global Neurosurgery Market Analysis and Forecast, by Indication Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Indication Type, 2020-2034
7.3.1. Brain Cancer
7.3.2. Spine and Skull base Tumors
7.3.3. Traumatic Brain Injuries
7.3.4. Craniofacial Trauma
7.3.5. Parkinson’s Disease
7.3.6. Tourette’s Syndrome
7.3.7. Others (Craniosynostosis, etc.)
7.4. Market Attractiveness Analysis, by Indication Type
8. Global Neurosurgery Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals & Specialty Clinics
8.3.2. Ambulatory Surgical Centers
8.3.3. Others (Academic and Specialized Neurological Institutes, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global Neurosurgery Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Neurosurgery Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2020-2034
10.3.1. Neuro Interventional Devices
10.3.2. Neuroendoscopes
10.3.3. Neurosurgical Drills
10.3.4. Radiosurgery Systems
10.3.5. Dura Substitutes
10.3.6. Neurosurgical Ablation Devices
10.3.7. Neurosurgery Instruments
10.4. Market Value Forecast, by Indication Type, 2020-2034
10.4.1. Brain Cancer
10.4.2. Spine and Skull base Tumors
10.4.3. Traumatic Brain Injuries
10.4.4. Craniofacial Trauma
10.4.5. Parkinson’s Disease
10.4.6. Tourette’s Syndrome
10.4.7. Others (Craniosynostosis, etc.)
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals & Specialty Clinics
10.5.2. Ambulatory Surgical Centers
10.5.3. Others (Academic and Specialized Neurological Institutes, etc.)
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product Type
10.7.2. By Indication Type
10.7.3. By End-user
10.7.4. By Country
11. Europe Neurosurgery Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2020-2034
11.3.1. Neuro Interventional Devices
11.3.2. Neuroendoscopes
11.3.3. Neurosurgical Drills
11.3.4. Radiosurgery Systems
11.3.5. Dura Substitutes
11.3.6. Neurosurgical Ablation Devices
11.3.7. Neurosurgery Instruments
11.4. Market Value Forecast, by Indication Type, 2020-2034
11.4.1. Brain Cancer
11.4.2. Spine and Skull base Tumors
11.4.3. Traumatic Brain Injuries
11.4.4. Craniofacial Trauma
11.4.5. Parkinson’s Disease
11.4.6. Tourette’s Syndrome
11.4.7. Others (Craniosynostosis, etc.)
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals & Specialty Clinics
11.5.2. Ambulatory Surgical Centers
11.5.3. Others (Academic and Specialized Neurological Institutes, etc.)
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Indication Type
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Neurosurgery Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2020-2034
12.3.1. Neuro Interventional Devices
12.3.2. Neuroendoscopes
12.3.3. Neurosurgical Drills
12.3.4. Radiosurgery Systems
12.3.5. Dura Substitutes
12.3.6. Neurosurgical Ablation Devices
12.3.7. Neurosurgery Instruments
12.4. Market Value Forecast, by Indication Type, 2020-2034
12.4.1. Brain Cancer
12.4.2. Spine and Skull base Tumors
12.4.3. Traumatic Brain Injuries
12.4.4. Craniofacial Trauma
12.4.5. Parkinson’s Disease
12.4.6. Tourette’s Syndrome
12.4.7. Others (Craniosynostosis, etc.)
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals & Specialty Clinics
12.5.2. Ambulatory Surgical Centers
12.5.3. Others (Academic and Specialized Neurological Institutes, etc.)
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Indication Type
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Neurosurgery Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product Type, 2020-2034
13.3.1. Neuro Interventional Devices
13.3.2. Neuroendoscopes
13.3.3. Neurosurgical Drills
13.3.4. Radiosurgery Systems
13.3.5. Dura Substitutes
13.3.6. Neurosurgical Ablation Devices
13.3.7. Neurosurgery Instruments
13.4. Market Value Forecast, by Indication Type, 2020-2034
13.4.1. Brain Cancer
13.4.2. Spine and Skull base Tumors
13.4.3. Traumatic Brain Injuries
13.4.4. Craniofacial Trauma
13.4.5. Parkinson’s Disease
13.4.6. Tourette’s Syndrome
13.4.7. Others (Craniosynostosis, etc.)
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals & Specialty Clinics
13.5.2. Ambulatory Surgical Centers
13.5.3. Others (Academic and Specialized Neurological Institutes, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Indication Type
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Neurosurgery Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product Type, 2020-2034
14.3.1. Neuro Interventional Devices
14.3.2. Neuroendoscopes
14.3.3. Neurosurgical Drills
14.3.4. Radiosurgery Systems
14.3.5. Dura Substitutes
14.3.6. Neurosurgical Ablation Devices
14.3.7. Neurosurgery Instruments
14.4. Market Value Forecast, by Indication Type, 2020-2034
14.4.1. Brain Cancer
14.4.2. Spine and Skull base Tumors
14.4.3. Traumatic Brain Injuries
14.4.4. Craniofacial Trauma
14.4.5. Parkinson’s Disease
14.4.6. Tourette’s Syndrome
14.4.7. Others (Craniosynostosis, etc.)
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals & Specialty Clinics
14.5.2. Ambulatory Surgical Centers
14.5.3. Others (Academic and Specialized Neurological Institutes, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Indication Type
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Medtronic plc
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Abbott Laboratories
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Boston Scientific Corporation
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Elekta
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Aleva Neurotherapeutics
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Machida Endoscope Co., Ltd.
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Brainlab
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. adeor Medical AG
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. LivaNova, plc
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. B. Braun
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Optofine Instruments Pvt. Ltd.
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. Wallaby Medical, LLC
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
15.3.13. Terumo Medical Corporation
15.3.13.1. Company Overview
15.3.13.2. Product Portfolio
15.3.13.3. SWOT Analysis
15.3.13.4. Financial Overview
15.3.13.5. Strategic Overview
15.3.14. Integra LifeSciences
15.3.14.1. Company Overview
15.3.14.2. Product Portfolio
15.3.14.3. SWOT Analysis
15.3.14.4. Financial Overview
15.3.14.5. Strategic Overview
15.3.15. Stryker Tech
15.3.15.1. Company Overview
15.3.15.2. Product Portfolio
15.3.15.3. SWOT Analysis
15.3.15.4. Financial Overview
15.3.15.5. Strategic Overview
List of Tables
Table 1: Global Neurosurgery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 2: Global Neurosurgery Market Size (US$ Bn) Forecast, by Indication Type, 2020-2034
Table 3: Global Neurosurgery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 4: Global Neurosurgery Market Size (US$ Bn) Forecast, by Region, 2020-2034
Table 5: North America Neurosurgery Market Size (US$ Bn) Forecast, by Country, 2020-2034
Table 6: North America Neurosurgery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 7: North America Neurosurgery Market Size (US$ Bn) Forecast, by Indication Type, 2020-2034
Table 8: North America Neurosurgery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 9: Europe Neurosurgery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Neurosurgery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 11: Europe Neurosurgery Market Size (US$ Bn) Forecast, by Indication Type, 2020-2034
Table 12: Europe Neurosurgery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific Neurosurgery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Neurosurgery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 15: Asia Pacific Neurosurgery Market Size (US$ Bn) Forecast, by Indication Type, 2020-2034
Table 16: Asia Pacific Neurosurgery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 17: Latin America Neurosurgery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Neurosurgery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 19: Latin America Neurosurgery Market Size (US$ Bn) Forecast, by Indication Type, 2020-2034
Table 20: Latin America Neurosurgery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa Neurosurgery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Neurosurgery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 23: Middle East & Africa Neurosurgery Market Size (US$ Bn) Forecast, by Indication Type, 2020-2034
Table 24: Middle East & Africa Neurosurgery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
List of Figures
Figure 1: Global Neurosurgery Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
Figure 2: Global Neurosurgery Market Revenue (US$ Bn), by Product Type, 2023
Figure 3: Global Neurosurgery Market Value Share, by Product Type, 2023
Figure 4: Global Neurosurgery Market Revenue (US$ Bn), by Indication Type, 2023
Figure 5: Global Neurosurgery Market Value Share, by Indication Type, 2023
Figure 6: Global Neurosurgery Market Revenue (US$ Bn), by End-user, 2023
Figure 7: Global Neurosurgery Market Value Share, by End-user, 2023
Figure 8: Global Neurosurgery Market Value Share, by Region, 2023
Figure 9: Global Neurosurgery Market Value (US$ Bn) Forecast, 2020-2034
Figure 10: Global Neurosurgery Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 11: Global Neurosurgery Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Neurosurgery Market Value Share Analysis, by Indication Type, 2023 and 2034
Figure 13: Global Neurosurgery Market Attractiveness Analysis, by Indication Type, 2024-2034
Figure 14: Neurosurgery Market Value Share Analysis, by End-user, 2023 and 2034
Figure 15: Global Neurosurgery Market Attractiveness Analysis, by End-user, 2024-2034
Figure 16: Global Neurosurgery Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Neurosurgery Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Neurosurgery Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Neurosurgery Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Neurosurgery Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Neurosurgery Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 22: North America Neurosurgery Market Value Share Analysis, by Indication Type, 2023 and 2034
Figure 23: North America Neurosurgery Market Value Share Analysis, by End-user, 2023 and 2034
Figure 24: North America Neurosurgery Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Neurosurgery Market Attractiveness Analysis, by Indication Type, 2024-2034
Figure 26: North America Neurosurgery Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Europe Neurosurgery Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Neurosurgery Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Neurosurgery Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Neurosurgery Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 31: Europe Neurosurgery Market Value Share Analysis, by Indication Type, 2023 and 2034
Figure 32: Europe Neurosurgery Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Europe Neurosurgery Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Neurosurgery Market Attractiveness Analysis, by Indication Type, 2024-2034
Figure 35: Europe Neurosurgery Market Attractiveness Analysis, by End-user, 2024-2034
Figure 36: Asia Pacific Neurosurgery Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Neurosurgery Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Neurosurgery Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Neurosurgery Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 40: Asia Pacific Neurosurgery Market Value Share Analysis, by Indication Type, 2023 and 2034
Figure 41: Asia Pacific Neurosurgery Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Asia Pacific Neurosurgery Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Neurosurgery Market Attractiveness Analysis, by Indication Type, 2024-2034
Figure 44: Asia Pacific Neurosurgery Market Attractiveness Analysis, by End-user, 2024-2034
Figure 45: Latin America Neurosurgery Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Neurosurgery Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Neurosurgery Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Neurosurgery Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 49: Latin America Neurosurgery Market Value Share Analysis, by Indication Type, 2023 and 2034
Figure 50: Latin America Neurosurgery Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Latin America Neurosurgery Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Neurosurgery Market Attractiveness Analysis, by Indication Type, 2024-2034
Figure 53: Latin America Neurosurgery Market Attractiveness Analysis, by End-user, 2024-2034
Figure 54: Middle East & Africa Neurosurgery Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Neurosurgery Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Neurosurgery Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Neurosurgery Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 58: Middle East & Africa Neurosurgery Market Value Share Analysis, by Indication Type, 2023 and 2034
Figure 59: Middle East & Africa Neurosurgery Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Middle East & Africa Neurosurgery Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Neurosurgery Market Attractiveness Analysis, by Indication Type, 2024-2034
Figure 62: Middle East & Africa Neurosurgery Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Neurosurgery Market
